Country: Kanada
Bahasa: Inggeris
Sumber: Health Canada
ETOPOSIDE
STRIDES PHARMA CANADA INC
L01CB01
ETOPOSIDE
20MG
SOLUTION
ETOPOSIDE 20MG
INTRAVENOUS
5/10/25/50ML
Prescription
ANTINEOPLASTIC AGENTS
Active ingredient group (AIG) number: 0114567002; AHFS:
APPROVED
2014-07-09
1 PRODUCT MONOGRAPH PR ETOPOSIDE INJECTION, USP (ETOPOSIDE 20 MG/ML) SOLUTION FOR INTRAVENOUS USE ANTINEOPLASTIC AGENT Strides Pharma Canada Inc. 1565, Boul. Lionel- Boulet Varennes, Quebec Canada, J3X 1P7 Submission Control No.: 241160 Date of Revision: August 10, 2020 2 PRODUCT MONOGRAPH PR ETOPOSIDE INJECTION, USP ETOPOSIDE 20 MG/ML SOLUTION FOR INTRAVENOUS USE THERAPEUTIC CLASSIFICATION Antineoplastic Agent CAUTION: ETOPOSIDE IS A POTENT DRUG AND SHOULD BE USED ONLY BY QUALIFIED PHYSICIANS EXPERIENCED WITH CANCER CHEMOTHERAPEUTIC DRUGS (SEE WARNINGS AND PRECAUTIONS). SEVERE MYELOSUPPRESSION WITH RESULTING INFECTION OR BLEEDING MAY OCCUR. BLOOD COUNTS AS WELL AS RENAL AND HEPATIC FUNCTION TESTS SHOULD BE TAKEN REGULARLY. DISCONTINUE THE DRUG IF ABNORMAL DEPRESSION OF BONE MARROW OR ABNORMAL RENAL OR HEPATIC FUNCTION IS SEEN. ETOPOSIDE INJECTION USP CONTAINS POLYSORBATE 80. IN PREMATURE INFANTS A LIFE THREATENING SYNDROME OF LIVER AND RENAL FAILURE, PULMONARY DETERIORATION, THROMBOCYTOPENIA AND ASCITES HAS BEEN ASSOCIATED WITH INJECTABLE VITAMIN E PRODUCT CONTAINING POLYSORBATE 80. ETOPOSIDE INJECTION USP CONTAINS BENZYL ALCOHOL. BENZYL ALCOHOL HAS BEEN ASSOCIATED WITH AN INCREASED INCIDENCE OF NEUROLOGICAL AND OTHER COMPLICATIONS IN NEWBORN INFANTS WHICH ARE SOMETIMES FATAL. ACTION AND CLINICAL PHARMACOLOGY Etoposide is a semi-synthetic derivative of podophyllotoxin used in the treatment of certain neoplastic diseases. _In vitro_ , etoposide has cytostatic action, which prevents the cells from entering mitosis or destroys them in the pre-mitotic phase. Etoposide interferes with the synthesis of DNA and has a secondary effect on arresting cells in resting (G2) phase in experiments with human lymphoblastic cell lines. Etoposide has a marked action on human hemopoietic cells causing leukopenia and thrombocytopenia. Animal experiments have shown evidence of teratogenicity. 3 An intravenous dose (259 mg/m 2 ) of tritium-labelled etoposide given over one hour in man, showed the mean volume of distribution to be 32% Baca dokumen lengkap